Please note: This website includes an accessibility system. Press Control-F11 to adjust the website to the visually impaired who are using a screen reader; Press Control-F10 to open an accessibility menu.

by

CTech 24/7

More stories in CTech

Fitch

8 stories about Fitch

Has Israel become too risky for foreign capital?
18.08.24|Adrian FilutCredit downgrades and rising CDS rates highlight deepening economic woes.
Fitch cuts Israel’s credit rating, citing geopolitical turmoil
13.08.24|ReutersGaza conflict and rising regional tensions drive negative outlook.
Fitch reaffirms Israel's A+ rating, removes Negative Watch
02.04.24|ReutersFitch ratings' outlook for Israel remains negative to "reflect the combination of uncertainties around the fiscal trajectory and the war's duration and intensity, including the risk of regional escalation."
Fitch Affirms Israel’s A+ Rating, Citing Strong Growth
01.09.19|Omri MilmanThe credit rating agency affirmed the rating with a stable outlook, estimating the deficit will grow to 3.6% of GDP in 2019, in line with the forecasts of the Israeli Ministry of Finance
Fitch Downgrades Teva, Keeps Outlook at Negative
10.06.19|Hezi SternlichtFitch pins the downgrade on the drugmaker's slow revenue growth, persisting cost challenges and downward pressure on generic drug prices, and the company's legal trouble in the U.S.
High Government Debt Countered by Strong Finances Leads Fitch to Affirm Israel's A+ Rating
26.03.19|Lilach BaumerIsrael scores above the median on GDP growth and human development indicators, but low on government budget deficit, government debt, and ease of doing business
JPMorgan Downgrades Teva’s Stock to Underweight
13.11.17|Amarelle WenkertChristopher Schott, managing director at JPMorgan, said that the decision to downgrade is based on the challenges facing Teva’s generic drug unit
Fitch Downgrades Teva to Junk Rating
07.11.17|Yaniv RahimiThe U.S. credit agency changed Teva's rating from BBB to BB, with a negative outlook, due to "significant operational stress." The downgrade might affect Teva's ability to take on additional debt

About CTech Terms of Use Privacy Policy

Back to Top